Fungisiso yeStock yeTG Therapeutics (TGTX)
AI forecast: TGTX
AI inoburitsa mutengo wechinangwa wezuva rinotevera rekutengesa, mugumo wevhiki uye mugumo wemwedzi. Shanduko inoyerwa kubva pamutengo wekupedzisira. Izvi zvinongova zvifungisiso zvehutano, hazviri mazano ekudyara.
Price over the last 6 months
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nzira yekufungisisa
Nzira yekufungisisa — yese fungisiso yekare pamwe chete nekukwira kwazvino — ndiyo Premium.
Unlock PremiumNdiyi ya Kompani Iyi
TG Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in the acquisition, development, and commercialization of innovative pharmaceutical products for the treatment of cancer and other underserved diseases. The company is developing two treatments for hematologic malignancies, specifically relapsed and refractory non-Hodgkin lymphoma.
